New Lonza Webinar — “Taking the Leap into an MES from a CEO’s Perspective”

April 20, 2023

On May 4, gain exclusive insight into the lessons the CEO of Exela® Pharma Sciences learned while implementing a Manufacturing Execution System (MES), and the lasting impact it will have on the company

Lonzas MODA-ES®On May 4, 2023, Lonza Bioscience Informatics will present a free 45-minute webinar that includes a discussion with Dr Phanesh Koneru, CEO, Exela® Pharma Sciences. During the conversation, Phanesh will share why adopting an MES was imperative to realizing the company’s vision, what he learned from his hands-on approach to implementation, and the impact the system is already having. As well as gathering exclusive insights from Phanesh, attendees will get the chance to ask Richard Kelley, Associate Director, Informatics, Lonza Bioscience, questions, and learn from his significant MES expertise.  

MES bring numerous benefits to pharma and biopharmaceutical manufacturers, from improved efficiencies to increased productivity. However, implementing an MES typically requires significant resources, planning and management, and has various hurdles to overcome including integrating MES into existing business critical applications. So, what was the impact of Phanesh not only setting the direction, but actively driving the adoption of an MES at Exela® Pharma, and how did he work with Lonza to ensure his business would reap the rewards of a digitalized system?

During the webinar “Taking the Leap into an MES from a CEO’s Perspective”, Phanesh and Richard will discuss a range of topics including:

  • Evaluation criteria for selecting an MES
  • Approach to validation
  • User adoption
  • The importance of vendor and service partner collaboration, and how these roles evolved over the project

Lonza has extensive knowledge and experience in developing informatics solutions to support and empower manufacturers. By hosting this webinar, Lonza hopes to provide a space where companies can come together and learn directly from organizations who have already embarked on their digitalization journey.  

Webinar: Taking the Leap into an MES from a CEO’s Perspective

Presenter: Richard Kelley, Associate Director, Informatics, Lonza Bioscience

Speaker: Dr Phanesh Koneru, CEO, Exela® Pharma Sciences

Thursday, May 4, 2023:

Europe and APAC:

9 AM CEST, 12.30 PM IST, 3 PM CST and SGT, 4 PM JST, 5 PM AEST

For more information on the webinar and how to register, visit our event page.  


AMERICAS and Europe


For more information on the webinar and how to register, visit the following event page.  

Further information on Lonza’s MES and digital solutions can be found on the website.

Lonza runs an extensive webinar program sharing expert know-how, useful tips, and the latest news from users as well as from Lonza’s R&D and Scientific Support Teams. For more information about upcoming and on-demand webinars please visit our webinar page.

Lonza Group Ltd has its headquarters in Basel, Switzerland, and is listed on the SIX Swiss Exchange. It has a secondary listing on the Singapore Exchange Securities Trading Limited (“SGX-ST”). Lonza Group Ltd is not subject to the SGX-ST’s continuing listing requirements but remains subject to Rules 217 and 751 of the SGX-ST Listing Manual.

Certain matters discussed in this media advisory may constitute forward-looking statements. These statements are based on current expectations and estimates of Lonza Group Ltd, although Lonza Group Ltd can give no assurance that these expectations and estimates will be achieved. Investors are cautioned that all forward-looking statements involve risks and uncertainty and are qualified in their entirety. The actual results may differ materially in the future from the forward-looking statements included in this media advisory due to various factors. Furthermore, except as otherwise required by law, Lonza Group Ltd disclaims any intention or obligation to update the statements contained in this media advisory.

Categories: Biomanufacturing, Pharma, Corporate, Finance & Investor
Browse more news

Recent releases